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Abstract
Membranous nephropathy is the most common cause of nephrotic syndrome in adults. A non-negligible
number of cases are associated with systemic conditions. We report a case of a 50-year-old man who
presented with nephrotic syndrome six months after being diagnosed with celiac disease. Although the
patient showed disappearance of circulating immunoglobulin A (IgA) anti-tissue transglutaminase
antibodies following a gluten-free diet, he had a sudden onset of nephrotic syndrome presenting with severe
hypoalbuminemia. Other secondary causes were promptly excluded leading to the assumption of celiac
disease-associated membranous nephropathy with remission after treatment with angiotensin system
blockade and a gluten-free diet. The goal of this case report is to alert the clinic towards this rare association
aiming for an early diagnosis and adequate selection of long-term therapy.
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Introduction
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in white Caucasian
adults, accounting for approximately 40% of cases [1]. MN is classically divided into two subgroups: primary
and secondary MN. Secondary MN constitutes around 20% of all MN cases and occurs in the context of
underlying conditions, namely malignancies, drugs, rheumatological diseases, and infections [2]. Celiac
disease (CD) is one of the most common autoimmune disorders, with a reported prevalence of 0.5-1% of the
general population [3]. Although the incidence of renal disease in CD patients is low and vice versa, this
association has pathogenic aspects that can affect both conditions. Here we report a case of MN in a patient
with CD and discuss the pitfalls of underlying investigation in this glomerular disease.
Case Presentation
The authors present a case of a 50-year-old Caucasian man with CD diagnosed in January 2020 and heavy
smoking habits (>25 cigarettes a day). He was referred to Nephrology Department in June 2020 due to recent
onset of generalized edema with an 8 kg weight gain and deterioration of renal function. On physical exam
he was normotensive and presented with bilateral pitting edema. Laboratory findings revealed decreased
renal function (serum creatinine 1.5 mg/dL as opposed to six months earlier 1 mg/dL), severe
hypoalbuminemia (albumin 17 g/L) and hypertriglyceridemia (triglycerides 550 mg/dL). Urinary analysis
showed proteinuria (4+) with a 24h urine protein excretion of 30 g. Kidney ultrasound was unremarkable
with normal kidneys. Considering a full-blown nephrotic syndrome with massive proteinuria, a renal biopsy
was performed revealing a membranous nephropathy (Figure 1).
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FIGURE 1: Immunoflurorescence microscopy
Granular deposition of IgG along the outer surface of capillary walls
Given his known CD and possible relationship with glomerulonephritis, analytical investigation was
extended and revealed disappearance of circulating immunoglobulin A (IgA) anti-tissue transglutaminase
antibodies following a six-month gluten-free diet. At this point, the hypothetical diagnosis of secondary MN
due to CD was temporarily postponed to exclude other further MN causes. Additional analysis revealed a low
titer of antinuclear antibodies (ANA; with a non-specific nucleolar pattern) (titer 1:320) and negative anti-
double-stranded DNA, rheumatoid factor, complement, anti-neutrophil cytoplasmic, and anti-
phospholipase A2 receptor antibodies (anti-PLA2R). Supplementary studies to characterize the ANA pattern
did not reveal any specific disease-associated autoantibodies. Nailfold capillaroscopy was performed,
excluding Raynaud’s phenomenon. Hepatitis B, C, and HIV were also excluded. Thoracic and abdominal
computed tomography scan, colonoscopy, and endoscopy were negative. Regarding his past medical history,
the patient had never received gold salts or nonsteroidal anti-inflammatory drugs. Considering the exclusion
of other secondary causes, the assumption of MN secondary to CD was made. A conservative approach was
initiated by ramipril until 15 mg a day in addition to a gluten-free diet. Rituximab was considered but
considering partial remission in two months to proteinuria under 6 g/day, the approach remained
conservative. Although the low evidence of MN and CD association reported, the presentation of full blow
nephrotic syndrome following CD diagnosis and the response to a gluten-free diet supported the diagnosis
of CD-associated MN.
Discussion
The association between CD and MN is rarely reported in the literature [4]. As both are immune-mediated
diseases, they possibly share an autoimmune pathogenesis with simultaneous digestive and renal
involvement. Some described an increase in the number of cases of chronic glomerulonephritis and renal
insufficiency in patients with CD and this risk is greater in adults [5]. By far the main association between
CD and glomerular disease is IgA nephropathy (IgAN) with 22-77% of patients with IgAN having IgA anti-
gliadin antibodies and 3-4% of these having CD [6,7]. In our case report the patient had histological
evidence of MN but no IgA deposits, excluding any resemblance to IgAN. In our opinion, the link between
CD and MN is not unexpected. Although there was a different temporal onset of both diseases the patient
had remission of massive proteinuria followed by disappearance of circulating IgA anti-tissue
transglutaminase antibodies. In fact, there was remission of both diseases, as is seen in the majority of cases
of secondary MN that remit when the original cause is addressed [8]. Anti-PLA2R autoantibodies are highly
specific for primary MN and are found in approximately 75% of patients at time of diagnosis [9]. We would
like to emphasize that our patient had negative anti-PLA2R leading us to secondary investigation as
recommended by the 2012 Kidney Disease Improving Global Outcomes (KDIGO) guidelines [10]. ANAs have
also been found in autoimmune diseases and cancer [11,12]. Its presence although unspecific alerts us to the
possibility of systemic lupus erythematosus (SLE) which has a known association with CD [13], and systemic
sclerosis (SS). The absence of clinical evidence of SLE (arthralgias, cutaneous lesions, photosensitivity,
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telangiectasia, hematological affection, or active urinary sediment) associated with the negative anti-DNA
antibodies excludes this diagnosis. In addition, the absence of Raynaud’s phenomenon, skin changes, and
unexplained dry month and eyes associated with negative specific antibodies disease do not contribute to
the diagnosis of SS nor Sjogren syndrome. Considering this, concerns of neoplasms were raised. Cancer
diagnosis accounts for 10% of secondary cases of MN, with lung and gastrointestinal systems the most
frequent [14]. These are sometimes diagnosed in a non-specific nucleolar ANA pattern without identified
autoantibody [12]. Regarding the patient's heavy smoking habits, MN-associated neoplasia was promptly
studied and excluded. We concluded our investigation with exclusion of specific MN-implicated drugs (gold
salt drugs and anti-nonsteroidal anti-inflammatory drugs). The assumption of secondary MN associated
with CD was made with the patient entering partial remission after two months of increasing angiotensin
blocker therapy and continuous gluten-free diet. Literature supports our case report in which the absence of
anti-PLA2R is associated with a higher likelihood of clinical remission [15].
Conclusions
Clinicians should be aware of the rare association between CD and MN. This must be considered in a patient
presenting with improvement of nephrotic syndrome after angiotensin blockage therapy and gluten-free
diet, despite the absence of IgA anti-tissue transglutaminase antibodies. Further studies are necessary to
elucidate the possible common pathogenic mechanisms of both diseases.
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